Back to companies
Karyopharm Therapeutics Inc.
KPTIUSNASDAQPharmaceuticals & HealthcareKaryopharm Therapeutics Inc.
Revenue
$146.1mn
YoY +0.6%
Operating income
-$90.7mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API